These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of apoptosis in circulating angiogenic cells by microparticles. Distler JH; Akhmetshina A; Dees C; Jüngel A; Stürzl M; Gay S; Pisetsky DS; Schett G; Distler O Arthritis Rheum; 2011 Jul; 63(7):2067-77. PubMed ID: 21437873 [TBL] [Abstract][Full Text] [Related]
6. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? Pericleous C; Giles I; Rahman A Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261 [TBL] [Abstract][Full Text] [Related]
7. Endothelial microparticles: a universal marker of vascular health? Shantsila E J Hum Hypertens; 2009 May; 23(5):359-61. PubMed ID: 19020535 [No Abstract] [Full Text] [Related]
8. Circulating endothelial microparticles as a marker of cerebrovascular disease. Jung KH; Chu K; Lee ST; Park HK; Bahn JJ; Kim DH; Kim JH; Kim M; Kun Lee S; Roh JK Ann Neurol; 2009 Aug; 66(2):191-9. PubMed ID: 19743467 [TBL] [Abstract][Full Text] [Related]
9. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689 [TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies. Duval A; Helley D; Capron L; Youinou P; Renaudineau Y; Dubucquoi S; Fischer AM; Hachulla E Rheumatology (Oxford); 2010 Jun; 49(6):1049-55. PubMed ID: 20211868 [TBL] [Abstract][Full Text] [Related]
11. Is endothelium the origin of endothelial progenitor cells? Yoder MC Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1094-103. PubMed ID: 20453169 [TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages. López M; San Román J; Estrada V; Vispo E; Blanco F; Soriano V AIDS Rev; 2012; 14(4):223-30. PubMed ID: 23258297 [TBL] [Abstract][Full Text] [Related]
13. The many faces of endothelial microparticles. Dignat-George F; Boulanger CM Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065 [TBL] [Abstract][Full Text] [Related]
14. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Tushuizen ME; Diamant M; Sturk A; Nieuwland R Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062 [TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells: characterization and role in vascular biology. Urbich C; Dimmeler S Circ Res; 2004 Aug; 95(4):343-53. PubMed ID: 15321944 [TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. Hill JM; Zalos G; Halcox JP; Schenke WH; Waclawiw MA; Quyyumi AA; Finkel T N Engl J Med; 2003 Feb; 348(7):593-600. PubMed ID: 12584367 [TBL] [Abstract][Full Text] [Related]
17. Cell-derived microparticles in haemostasis and vascular medicine. Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403 [TBL] [Abstract][Full Text] [Related]
18. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Steiner S; Schaller G; Puttinger H; Födinger M; Kopp CW; Seidinger D; Grisar J; Hörl WH; Minar E; Vychytil A; Wolzt M; Sunder-Plassmann G Am J Kidney Dis; 2005 Sep; 46(3):520-8. PubMed ID: 16129215 [TBL] [Abstract][Full Text] [Related]
19. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Werner N; Wassmann S; Ahlers P; Kosiol S; Nickenig G Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):112-6. PubMed ID: 16239600 [TBL] [Abstract][Full Text] [Related]
20. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Connor DE; Exner T; Ma DD; Joseph JE Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]